Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A man lost all his hair permanently after hepatitis C treatment, a side effect not seen before.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Wnt5a may contribute to psoriasis by reducing skin cell growth, blocking skin cell maturation, and increasing inflammation.

A man lost all his hair as a rare side effect after hepatitis C treatment.

Nail loss may be a side effect of the MS drug teriflunomide.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Permanent hair dye may cause total hair loss.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

ILC1 cells contribute to hair loss in alopecia areata.

The combination therapy was effective and well-tolerated, especially in young patients.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Erdr1 could be a new marker for diagnosing hair loss.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Certain gene variations may increase the risk and severity of alopecia areata.

Leflunomide is more likely to help treat alopecia areata than cause it.

Imiquimod improved skin pigmentation in most patients with xeroderma pigmentosum and may prevent further skin cancer, but some treatments can have side effects.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

The health of the sentinel lymph node is the best indicator of survival for patients with thick skin cancer.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

Upadacitinib may effectively treat alopecia areata without side effects.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

SH-MSCs gel can effectively treat alopecia by increasing IL-10 and decreasing TNF-α gene expression.